Main
Alzheimer’s disease, AD, primary tauopathies, neurodegenerative disease
NEURODEGENERATIVE DISEASE
Alzheimer’s disease (AD) is a progressive neurodegenerative disease with a high unmet needGosuranemab is a humanized immunoglobulin G4 monoclonal antibody to N-terminal tauThe safety, efficacy, pharmacokinetics and pharmacodynamics of gosuranemab have been evaluated in previous clinical trialsHowever, because AD is pathologically and clinically distinct from primary tauopathies